Day: October 4, 2020

Sorrento to Host a R&D Day to Showcase COVID-19 Product Pipeline

SAN DIEGO, Oct. 04, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced it will host a R&D Day conference call and simultaneous webcast on October 13th, 2020 focusing on its comprehensive multi-modal approach to COVID-19.During this 90-minute event, management will highlight continued strategic advancement, challenges, key pipeline updates and drivers of future growth in the COVID-19 space. Thirty minutes will be reserved for analyst questions. The audio webcast and transcript will be available on the Sorrento website for 30 days following the event.Participants will include:Dr. Henry Ji, Chairman and CEODr. Mike Royal, Chief Medical OfficerDr. Mark Brunswick, SVP and Head of Regulatory and QualityDr. Robert Allen, SVP and Antiviral and Oncolytic Immunotherapy DevelopmentDr. Alexis...

Continue reading

IDEX Biometrics: Subscription Rights Exchange Program 2 Oct 2020

The annual general meeting of IDEX Biometrics ASA on 15 May 2020 authorized that employees and individual contractors in IDEX who held incentive subscription rights under the Company’s incentive subscription rights programs 2016, 2017 and/or 2018 (Existing SRs), could receive replacement subscription rights (Replacement SRs) the against waiver of the Existing SRs.The board resolved on 2 October 2020 to replace a combined total of 25,962,800 incentive SRs from the incentive plans for 2016, 2017 or 2018, by the same number of Replacement SRs under the Company’s 2020 Subscription Rights Incentive Plan. The outstanding number of SRs will remain unchanged at 55,993,593.According to the resolution by the annual general meeting, the exercise price of the Replacement SRs is NOK 1.71 per share, and 1/3 of the Replacement SRs vest on 15 April 2021,...

Continue reading

Colliers International appoints new Managing Director for Japan business

TOKYO, Oct. 04, 2020 (GLOBE NEWSWIRE) — Leading global commercial real estate services and investment management firm, Colliers International (NASDAQ and TSX: CIGI) today announced that Yukihiro Ogasawara has been appointed as Managing Director & Chairman | Japan.Ogasawara joins Colliers Japan from CBRE, where he was Vice Chairman of Capital Markets and led a strategy to advise Japanese capital for investment into regional and global markets.Ogasawara brings across more than 40 years of expertise in recruiting teams, sourcing domestic and foreign capital; structuring finance deals; and overseeing the acquisition and management of office, hotel, residential and land developments.Prior to CBRE, he forged an impressive career with Sumitomo Realty & Development Co., Ltd. in both Japan and the United States, serving as General...

Continue reading

Festi hf.: Buy-back Programme

The Annual General Meeting of Festi held 23 March 2020 empowered the Board of Directors, pursuant to Article 55 of the Company Act No 2/1995, to purchase upto 10% of the company‘s shares on its behalf. The purpose of the programme is to decrease the number of issued shares.The Board of Directors of Festi has on the basis of the mandate issued by the Annual General Meeting adopted a decision on the execution of a buy-back programme. The aim is to buy back own shares for the maximum amount of 4,000,000 shares or 1,2% of issued shares, the total amount of the buy-back however not exceeding 600,000,000 ISK in purchase price.The buy-back will be executed in stages, with the maximum amount of shares set at 194,000 shares equivalent to 25% of the average daily trade in the company‘s shares on Nasdaq OMX Iceland in September 2020. The share price...

Continue reading

Festi hf.: Tilkynning um framkvæmd endurkaupaáætlunnar

Aðalfundur Festi hf., sem haldinn var 23. mars 2020, veitti stjórn félagsins heimild, á grundvelli 55. gr. laga um hlutafélög, nr. 2/1995, að kaupa fyrir hönd félagsins allt að 10% af hlutafé þess. Markmið áætlunarinnar er að lækka útgefið hlutafé félagsins.Stjórn Festi hf. hefur á grundvelli samþykktar aðalfundar tekið ákvörðun um framkvæmd endurkaupaáætlunar Áætlað er að kaupa á hámarki 4.000.000 eigin hluti í félaginu eða sem samsvarar 1,2% af útgefnu hlutafé, þó þannig að fjárhæð endurkaupanna verði aldrei meiri en 600 milljónum króna að kaupverði.Kaupin verða framkvæmd í áföngum, þó þannig að kaup hvers dags verða að hámarki 194.000 hlutir sem jafngildir 25% af meðaltali daglegra viðskipta með hlutabréf félagsins á Nasdaq OMX á Íslandi í september 2020. Endurgjald fyrir hvern hlut skal að hámarki vera hæsta verð í síðustu óháðu viðskiptum...

Continue reading